# CM336 for Active Sjogren's Syndrome Study

> **NCT07642843** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Primary Sjögren's Syndrome (pSS)

## Interventions

- **BIOLOGICAL:** CM336

## Key facts

- **NCT ID:** NCT07642843
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-04
- **Final completion:** 2029-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07642843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07642843, "CM336 for Active Sjogren's Syndrome Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07642843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*